Holen Sie sich die Stockscreener-App
5.73
0.35%
-0.02
Handel nachbörslich:
5.74
0.010
+0.17%
Recursion Pharmaceuticals Inc Aktie (RXRX) Neueste Nachrichten
Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings - MSN
Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade) (NASDAQ:RXRX) - Seeking Alpha
Promising Biotech Stocks To ResearchOctober 19th - MarketBeat
When is the best time to exit Recursion Pharmaceuticals Inc.Breakout Watch & Weekly Chart Analysis and Guides - newser.com
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
Will Recursion Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Is it time to cut losses on Recursion Pharmaceuticals Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Growth or Bubble? Decoding Recursion Pharmaceuticals Stock - StocksToTrade
Recursion Pharmaceuticals Stock: Growth or Bubble? - StocksToTrade
Top Biotech Stocks To Keep An Eye OnOctober 22nd - MarketBeat
Jim Cramer on Recursion Pharmaceuticals: “Now, It’s a Meme Stock” - Yahoo Finance
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com
Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event - MSN
Has Recursion Pharmaceuticals Inc. formed a bullish divergenceTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Why RXRX’s Stock Came Tumbling Down? - timothysykes.com
What drives Recursion Pharmaceuticals Inc stock priceStock Price Divergence & Invest Like A Pro - earlytimes.in
RXRX Stock’s Unexpected Surge: Analyzing Future Trends - StocksToTrade
Top Biotech Stocks To ResearchOctober 21st - MarketBeat
Up 25% in 1 Month, Is This Stock a Buy? - AOL.com
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares - AOL.com
Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Navigating the Biotech Frontier with a 33.3% Revenue Surge - DirectorsTalk Interviews
How to recover losses in Recursion Pharmaceuticals Inc. stockForecast Cut & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-10-20 23:47:28 - newser.com
Will Recursion Pharmaceuticals Inc. stock recover faster than marketInflation Watch & Expert Approved Trade Ideas - newser.com
Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionDay Trade & Real-Time Stock Price Movement Reports - newser.com
Lightning Round: Recursion Pharma is now a meme stock, says Jim Cramer - MSN
Advanced analytics toolkit walkthrough for Recursion Pharmaceuticals Inc.July 2025 Volume & Smart Investment Allocation Insights - newser.com
Is Recursion Pharmaceuticals Set for Further Gains After Recent 36% Share Price Surge? - Yahoo Finance
Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? - Yahoo Finance
Recursion Pharmaceuticals (RXRX): Evaluating Valuation After AI Collaborations, Exscientia Deal, and Industry Leadership Moves - simplywall.st
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.Options Play & Expert-Curated Trade Recommendations - newser.com
Recursion Pharmaceuticals Inc. stock volume spike explainedWeekly Stock Analysis & Daily Stock Trend Reports - newser.com
Recursion Pharma Stock Soars 16% on AI Buzz and Big Pharma Deals – Can RXRX Keep Climbing? - ts2.tech
Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships - Quiver Quantitative
Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares - The Motley Fool
Why Recursion Pharmaceuticals Stock is Soaring - TipRanks
AI in Biotechnology Research Report 2025: An $11.4 Billion - GlobeNewswire
AI in Biotechnology Research Report 2025: An $11.4 Billion Market by 2030, Dominated by NVIDIA, Tempus AI, Recursion Pharmaceuticals, Schrodinger, and Sophia Genetics - Yahoo Finance
Recursion Pharmaceuticals call volume above normal and directionally bullish - TipRanks
10 Big Names Beating Wall Street at its Own Game - Insider Monkey
Recursion Pharmaceuticals Stock Analysis: Key Updates and Financial Overview - StocksToTrade
Recursion (RXRX) Gains After Acquiring Exscientia and Expanding AI Pharma Partnerships Has the Risk Profile Shifted? - simplywall.st
What analysts say about Recursion Pharmaceuticals Inc stockGeopolitical Risk Analysis & Small Budget Capital Gains - earlytimes.in
Is Recursion Pharmaceuticals Inc. stock a top momentum playJuly 2025 Fed Impact & Free Reliable Trade Execution Plans - nchmf.gov.vn
Market Moves: Is Recursion Pharmaceuticals Inc. stock a smart buy before Fed meetingJuly 2025 Setups & Safe Entry Trade Signal Reports - nchmf.gov.vn
Recursion Pharmaceuticals Hits Day High with 15.28% Surge in Stock Price - Markets Mojo
Great Week for Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Institutional Investors After Losing 2.9% Over the Previous Year - 富途牛牛
0.03%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):